Addition of HER2 and CD44 to (18)F-FDG PET–based clinico-radiomic models enhances prediction of neoadjuvant chemoradiotherapy response in esophageal cancer

OBJECTIVES: To assess the complementary value of human epidermal growth factor receptor 2 (HER2)-related biological tumor markers to clinico-radiomic models in predicting complete response to neoadjuvant chemoradiotherapy (NCRT) in esophageal cancer patients. METHODS: Expression of HER2 was assessed...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur Radiol
Autori principali: Beukinga, Roelof J., Wang, Da, Karrenbeld, Arend, Dijksterhuis, Willemieke P. M., Faber, Hette, Burgerhof, Johannes G. M., Mul, Véronique E. M., Slart, Riemer H. J. A., Coppes, Robert P., Plukker, John Th. M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2020
Soggetti:
Gastrointestinal
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8043921/
https://ncbi.nlm.nih.gov/pubmed/33151397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00330-020-07439-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi